Qu CF - Search Results

1

Pre-clinical study of 213Bi labeled PAI2 for the control of micrometastatic pancreatic cancer.

Qu CF, Song EY, Li Y, Rizvi SM, Raja C, Smith R, Morgenstern A, Apostolidis C, Allen BJ. Qu CF, et al. Clin Exp Metastasis. 2005;22(7):575-86. doi: 10.1007/s10585-005-5788-9. Epub 2006 Feb 11. Clin Exp Metastasis. 2005. PMID: 16475028

2

Cytotoxicity of human prostate cancer cell lines in vitro and induction of apoptosis using 213Bi-Herceptin alpha-conjugate.

Li Y, Cozzi PJ, Qu CF, Zhang DY, Abbas Rizvi SM, Raja C, Allen BJ. Li Y, et al. Among authors: qu cf. Cancer Lett. 2004 Mar 18;205(2):161-71. doi: 10.1016/j.canlet.2003.10.035. Cancer Lett. 2004. PMID: 15036648

3

Antigenic expression of human metastatic prostate cancer cell lines for in vitro multiple-targeted alpha-therapy with 213Bi-conjugates.

Li Y, Abbas Rizvi SM, Blair nee Brown JM, Cozzi PJ, Qu CF, Ow KT, Tam PN, Perkins AC, Russell PJ, Allen BJ. Li Y, et al. Among authors: qu cf. Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):896-908. doi: 10.1016/j.ijrobp.2004.04.035. Int J Radiat Oncol Biol Phys. 2004. PMID: 15465208

4

Cytotoxicity of PAI2, C595 and Herceptin vectors labeled with the alpha-emitting radioisotope Bismuth-213 for ovarian cancer cell monolayers and clusters.

Song YJ, Qu CF, Rizvi SM, Li Y, Robertson G, Raja C, Morgenstern A, Apostolidis C, Perkins AC, Allen BJ. Song YJ, et al. Among authors: qu cf. Cancer Lett. 2006 Mar 28;234(2):176-83. doi: 10.1016/j.canlet.2005.03.060. Epub 2005 Jun 14. Cancer Lett. 2006. PMID: 15961220

5

In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595.

Qu CF, Songl YJ, Rizvi SM, Li Y, Smith R, Perkins AC, Morgenstern A, Brechbiel M, Allen BJ. Qu CF, et al. Cancer Biol Ther. 2005 Aug;4(8):848-53. doi: 10.4161/cbt.4.8.1892. Cancer Biol Ther. 2005. PMID: 16082185 Free article.

6

Control of prostate cancer spheroid growth using 213Bi-labeled multiple targeted alpha radioimmunoconjugates.

Wang J, Abbas Rizvi SM, Madigan MC, Cozzi PJ, Power CA, Qu CF, Morgenstern A, Apostolidis C, Russell PJ, Allen BJ, Li Y. Wang J, et al. Among authors: qu cf. Prostate. 2006 Dec 1;66(16):1753-67. doi: 10.1002/pros.20502. Prostate. 2006. PMID: 16955401

7

Pharmacokinetics and toxicity of (213)Bi-labeled PAI2 in preclinical targeted alpha therapy for cancer.

Song EY, Abbas Rizvi SM, Qu CF, Raja C, Brechbiel MW, Morgenstern A, Apostolidis C, Allen BJ. Song EY, et al. Among authors: qu cf. Cancer Biol Ther. 2007 Jun;6(6):898-904. doi: 10.4161/cbt.6.6.4097. Epub 2007 Mar 5. Cancer Biol Ther. 2007. PMID: 17582216 Free article.

8

Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model.

Song EY, Qu CF, Rizvi SM, Raja C, Beretov J, Morgenstern A, Apostolidis C, Bruchertseifer F, Perkins A, Allen BJ. Song EY, et al. Among authors: qu cf. Cancer Biol Ther. 2008 Jan;7(1):76-80. doi: 10.4161/cbt.7.1.5132. Epub 2007 Oct 8. Cancer Biol Ther. 2008. PMID: 18347423 Free article.

9

The cytokinesis-block micronucleus assay as a biological dosimeter for targeted alpha therapy.

Song EY, Rizvi SM, Qu CF, Raja C, Yuen J, Li Y, Morgenstern A, Apostolidis C, Allen BJ. Song EY, et al. Among authors: qu cf. Phys Med Biol. 2008 Jan 21;53(2):319-28. doi: 10.1088/0031-9155/53/2/001. Epub 2007 Dec 28. Phys Med Biol. 2008. PMID: 18184988

10

Targeted alpha therapy approach to the management of pancreatic cancer.

Allen BJ, Rizvi SM, Qu CF, Smith RC. Allen BJ, et al. Among authors: qu cf. Cancers (Basel). 2011 Apr 1;3(2):1821-43. doi: 10.3390/cancers3021821. Cancers (Basel). 2011. PMID: 24212784 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters